Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) CEO David Elsley joined Steve Darling from Proactive to bring news the company has hit a major corporate milestone as they begin trading on the Nasdaq Exchange under the ticker “CRDL” Elsley telling Proactive the company will continue to trade on the Toronto Stock Exchange with the ticker “CRDL”
Elsley also shared why this is so big for Cardiol because the NASDAQ is the premier global stock exchange for life science and biotechnology companies.